US Broker Ratings

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings and Impressive 10.65% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology industry, continues to capture investor attention with its robust portfolio of innovative pharmaceutical products. With..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring a 8.03% Potential Upside in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector with a market capitalization of $6.16 billion, is carving out its niche in the..

BioNTech SE (BNTX) Stock Analysis: Navigating a 4.14% Upside Amidst Revenue Challenges

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector known for its groundbreaking mRNA technologies, is currently trading at $116.57, near the upper end..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a 37% Downside in Biotech’s Dynamic Future

Moderna, Inc. (NASDAQ: MRNA) has become a prominent name in the biotechnology sector, primarily known for its groundbreaking work in messenger RNA (mRNA) technology. As the..

McKesson Corporation (MCK) Stock Analysis: A Healthcare Giant with a 14.91% Upside Potential

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, is capturing the attention of investors with its robust market presence and promising growth potential. As..

Alcon Inc. (ALC): Investor Outlook on Its 15.77% Potential Upside

Alcon Inc. (NYSE: ALC), a heavyweight in the medical instruments and supplies sector, continues to draw investor attention with its promising growth potential. Specializing in eye..

Alkermes plc (ALKS) Investor Outlook: Analyzing 15.87% Potential Upside in the Biopharma Sector

Alkermes plc (NASDAQ: ALKS), a prominent player in the biopharmaceutical space, has recently caught the attention of investors aiming to capitalize on healthcare innovations. Headquartered in..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Report: Analysts See 31% Upside Potential with Strong Buy Ratings

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is capturing the attention of investors with its promising position in the biotechnology sector, particularly in the treatment of metabolic dysfunction-associated..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Capturing 10% Upside Potential with Innovative Medical Devices

GE HealthCare Technologies Inc. (NYSE: GEHC), a prominent player in the healthcare sector, commands a market capitalization of $33.8 billion. With its roots in the development,..

Elanco Animal Health (ELAN) Stock Analysis: Unlocking a 30% Upside Potential with Strong Buy Ratings

Elanco Animal Health Incorporated (NYSE: ELAN) is making waves in the healthcare sector, specifically within the realm of drug manufacturing for specialty and generic animal health..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Strong Healthcare Contender with 22.58% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) is making waves in the healthcare sector, particularly in the medical care facilities industry. With a market capitalization of $10.46..

argenx SE (ARGX) Stock Analysis: Unpacking the 12.79% Potential Upside in Biotech Innovation

argenx SE (NASDAQ: ARGX), a trailblazer in the biotechnology sector, is capturing investor attention with its promising therapeutic pipeline and robust market performance. Based in the..

Universal Health Services, Inc. (UHS) Stock Analysis: Evaluating a 9.41% Potential Upside Amid Healthcare Growth

Universal Health Services, Inc. (NYSE: UHS) stands as a prominent player in the healthcare sector, specializing in medical care facilities across the United States. With a..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 29.47% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR) stands prominently in the healthcare sector as a leader among specialty and generic drug manufacturers. With a market capitalization of $22.01..

Summit Therapeutics Inc. (SMMT): Growth Potential and Analyst Consensus with 117.45% Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) stands as a noteworthy player in the biotechnology sector, specializing in the discovery and development of innovative therapies aimed at addressing..

West Pharmaceutical Services (WST) Stock Analysis: Riding a 14.63% Potential Upside with Strong Analyst Confidence

West Pharmaceutical Services, Inc. (NYSE: WST) continues to capture investor attention with its solid positioning in the healthcare sector, specifically within the medical instruments and supplies..

Penumbra, Inc. (PEN) Stock Analysis: Exploring Growth Potential and Market Position

Penumbra, Inc. (PEN), a prominent player in the healthcare sector, continues to capture investor attention with its innovative medical devices. Based in Alameda, California, Penumbra designs,..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A 10.46% Upside Potential Awaits Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI) has been capturing attention in the healthcare sector with its solid performance and promising growth outlook. The company, established in..

BridgeBio Pharma (BBIO) Stock Analysis: Strong Buy Ratings and 33% Potential Upside Captivate Investors

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a key player in the biotechnology sector, has been making waves with its robust pipeline of therapies aimed at genetic diseases...

Molina Healthcare Inc (MOH) Stock Analysis: A Mixed Outlook with Modest Upside Potential

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, presents a complex investment scenario for individual investors seeking exposure in the healthcare..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds